Skip to content

Spinal stenosis — overview

TL;DR — Spinal stenosis is clinically meaningful narrowing that compromises nerve roots or cord; imaging alone is insufficient. Lumbar stenosis classically causes posture- and walking-dependent leg symptoms, while cervical cord compression may cause hand dysfunction, gait imbalance, hyperreflexia and sphincter deterioration (Katz 2022, PMID 35503342; Fehlings 2017, PMID 29164035). Multimodal exercise/manual care can help lumbar neurogenic claudication, whereas epidural glucocorticoid has little added short-term benefit over anesthetic alone (Bussières 2021, PMID 33857615; Friedly 2014, PMID 24988555). Decompression helps selected persistent disabling lumbar cases; adding fusion is frequently unnecessary even with stable degenerative spondylolisthesis (Weinstein 2010, PMID 20453723; Austevoll 2021, PMID 34347953). Progressive cervical myelopathy and cauda-equina syndrome are safety-critical exceptions to routine conservative pacing.

Definition and diagnostic anchors

  • Lumbar stenosis may be central, lateral-recess or foraminal. The clinical syndrome is neurogenic claudication or radiculopathy attributable to narrowing.
  • Neurogenic claudication usually worsens with standing/walking or lumbar extension and improves with sitting/flexion; vascular claudication, hip disease and peripheral neuropathy are key mimics (Genevay 2010, PMID 20227646).
  • Cervical degenerative myelopathy arises when cord compression produces long-tract dysfunction: hand clumsiness, gait imbalance, weakness, hyperreflexia, pathological reflexes or sphincter change (McCormick 2020, PMID 32179614).
  • Cauda-equina syndrome—new urinary retention/incontinence, saddle sensory loss, bilateral deficits or severe progressive weakness—requires emergency evaluation (Kuris 2021, PMID 34473966).
  • MRI defines anatomy and excludes other lesions, but symptom concordance matters. History and examination features have imperfect diagnostic accuracy, and guidance treats diagnosis as a clinical–imaging synthesis (Cook 2020, PMID 31312914; Kreiner 2013, PMID 23830297).

Epidemiology and natural history

A systematic review found highly variable lumbar-stenosis prevalence because radiological and clinical definitions differ; estimates are higher in secondary-care and older populations (Jensen 2020, PMID 32095908). This heterogeneity means no single prevalence should be quoted without its case definition.

Stable lumbar symptoms can fluctuate and do not invariably deteriorate. Cervical myelopathy is less forgiving: progression is variable but potentially irreversible, and nonmyelopathic compression must be separated from clinical cord dysfunction (Matz 2009, PMID 19769489; Fehlings 2017, PMID 29164035).

Mechanism sketch

Facet hypertrophy, ligamentum-flavum thickening, disc height loss/bulging and spondylolisthesis reduce available space. Extension further narrows the lumbar canal/foramina; flexion opens them. Symptoms reflect mechanical deformation plus venous congestion, ischemia and inflammatory sensitivity rather than a fixed diameter alone (Genevay 2010, PMID 20227646).

In cervical disease, chronic compression and repetitive shear injure axons, oligodendrocytes and microvasculature. T2 cord signal change may indicate injury but does not perfectly predict function or recovery.

Diagnosis

History of leg/buttock symptoms worsened by standing/walking and relieved by sitting or flexion is more informative than back pain alone. Examination assesses strength, reflexes, sensation, pulses, hip motion, gait and balance. A systematic review found individual history/physical findings have limited standalone accuracy, supporting pattern-based diagnosis (Cook 2020, PMID 31312914).

Objective walking tests can quantify a patient's actual limitation and treatment response, complementing questionnaires. Digital gait markers are emerging but not yet validated decision tools (Morimoto 2023, PMID 38162877).

Treatment landscape

Nonoperative lumbar care

A clinical practice guideline recommends multimodal nonpharmacological care—education, home exercise, manual therapy and/or rehabilitation—rather than routine epidural steroid injection for neurogenic claudication (Bussières 2021, PMID 33857615). Updated systematic review supports a multimodal program, while evidence for many isolated modalities is low quality (Ammendolia 2022, PMID 35046008).

Exercise trials commonly include supervised flexion-tolerant conditioning, strengthening, walking/cycling and behaviorally supported progression; no single component has established dominance (Comer 2024, PMID 37715644). A randomized comparative-effectiveness trial supported manual therapy/individualized exercise over group exercise or medical care at short-term endpoints (Schneider 2019, PMID 30646197).

In a 400-patient randomized trial, epidural glucocorticoid plus lidocaine produced minimal or no additional short-term benefit over lidocaine alone and more adverse events/cortisol suppression (Friedly 2014, PMID 24988555).

Lumbar surgery

SPORT showed greater improvement with decompressive surgery than nonoperative care in as-treated analyses through four years, but high crossover complicates randomized interpretation (Weinstein 2010, PMID 20453723). At eight years, advantages narrowed in the randomized cohort while persisted in the observational cohort, underscoring selection and attrition (Lurie 2015, PMID 25569524). Cochrane review judged comparative evidence limited and surgical complications non-trivial (Zaina 2016, PMID 26824399).

Decompression versus fusion

Fusion adds operative time, blood loss, implant risk and adjacent-segment consequences. A Swedish randomized trial found no better clinical outcome from adding fusion to decompression in stenosis with or without spondylolisthesis (Försth 2016, PMID 27074066).

NORDSTEN-DS found decompression alone non-inferior to decompression plus fusion at two years in degenerative spondylolisthesis (Austevoll 2021, PMID 34347953); five-year follow-up maintained non-inferiority (Kgomotso 2024, PMID 39111800). Individual instability and deformity still matter, but “spondylolisthesis present” is not an automatic fusion indication.

Meta-analysis likewise finds no routine patient-reported advantage from adding fusion, while remaining limited by heterogeneous selection and instability definitions (Gadjradj 2023, PMID 36609887).

Interspinous devices aim to preserve motion with less invasive treatment, but reoperation and device-specific harms require long follow-up. A 5-year randomized comparison with conventional decompression provides one evidence anchor (Schenck 2022, PMID 34952518). Device-specific review reinforces that an implant class cannot be judged without its comparator and later conversion burden (Ramesh 2016, PMID 26324829).

Cervical myelopathy

Guidance recommends surgery for moderate/severe degenerative cervical myelopathy and for neurological deterioration; mild disease can be managed with surgery or a supervised rehabilitation trial with close monitoring (Fehlings 2017, PMID 29164035). Nonmyelopathic cord compression is not equivalent to myelopathy.

Research frontier

  • Standard clinical–imaging definitions that make prevalence and trials comparable.
  • Predicting who will improve with decompression versus structured rehabilitation.
  • Objective walking and gait endpoints that reflect daily function (Morimoto 2023, PMID 38162877).
  • Identifying true instability that justifies fusion rather than using static labels.
  • Neuroprotective adjuncts for cervical cord compression; riluzole secondary analyses have not established routine use (Fehlings 2024, PMID 38904964).

Phenotype map

Phenotype Defining clinical problem Anatomical substrate Dominant outcome Safety pivot
Lumbar central stenosis Posture-dependent bilateral or multilevel leg symptoms Central canal crowding Walking time/distance New cauda-equina dysfunction
Lumbar lateral-recess stenosis Traversing-root radicular pattern, sometimes with claudication Subarticular narrowing Root-specific function plus walking Progressive motor deficit
Lumbar foraminal stenosis Exiting-root pain, sensory change or weakness Foraminal height/area loss Leg pain and neurological function Progressive motor deficit
Cervical radiculopathy Segmental arm pain/weakness without cord signs Foraminal/root compression Arm function and pain Emerging long-tract signs
Degenerative cervical myelopathy Hand dysfunction, gait imbalance and long-tract signs Cord compression mJOA, dexterity, gait and falls Neurological deterioration
Imaging-only narrowing No concordant neural syndrome Canal/foraminal narrowing Longitudinal clinical status New symptoms or signs

The phenotype distinction is not semantic. Radiological stenosis is common in people without a concordant syndrome, and the pooled radiological prevalence in asymptomatic populations was 11% (95% CI 5–18%) (Jensen 2020, PMID 32095908). Conversely, a dynamic walking syndrome or early myelopathy can be consequential before a single static measurement appears extreme. The diagnostic unit is therefore the clinical–anatomical pattern, not the scan label.

Decision architecture

  1. Define the syndrome. Separate claudication, radiculopathy, myelopathy and acute cauda-equina dysfunction.
  2. Localize and test concordance. Use examination and MRI/CT to identify a plausible level and compartment; do not convert incidental narrowing into causation (Cook 2020, PMID 31312914).
  3. Measure trajectory and function. Record walking, hand function, falls, objective deficit and participation rather than pain alone (Morimoto 2023, PMID 38162877).
  4. Identify the safety pathway. Acute sacral-root dysfunction and progressive cord disease override routine pacing (Kuris 2021, PMID 34473966; Fehlings 2017, PMID 29164035).
  5. Compare complete strategies. For lumbar disease, structured rehabilitation, decompression, decompression plus fusion and device pathways differ in recovery and repeat-treatment burden—not only short-term pain.
  6. Make uncertainty visible. SPORT crossover, inconsistent imaging thresholds and unstable definitions of lumbar instability are features of the evidence base, not details to hide (Lurie 2015, PMID 25569524).

What the major trials actually establish

Evidence anchor Population/comparison Quantitative result Boundary
Epidural trial 400 patients; glucocorticoid + lidocaine vs lidocaine RMDQ difference −1.0 (95% CI −2.1 to 0.1); leg pain −0.2/10 (−0.8 to 0.4) at 6 weeks Added steroid effect, not injection vs no injection (Friedly 2014, PMID 24988555)
SPORT, 4 years Decompression vs nonoperative strategy As-treated surgical advantages persisted High crossover limits randomized inference (Weinstein 2010, PMID 20453723)
SPORT, 8 years Same program, extended follow-up Randomized-cohort advantage converged; observational advantage persisted Attrition and subsequent treatment (Lurie 2015, PMID 25569524)
Swedish trial Decompression vs decompression + fusion No superior clinical outcome from added fusion Stenosis with or without spondylolisthesis (Försth 2016, PMID 27074066)
NORDSTEN-DS Degenerative spondylolisthesis Decompression alone noninferior at 2 and 5 years Does not erase selected deformity/instability indications (Austevoll 2021, PMID 34347953; Kgomotso 2024, PMID 39111800)

Evidence-reading cautions

  • A within-group improvement after injection or implantation does not establish superiority over rehabilitation or conventional decompression.
  • A device-versus-device noninferiority trial answers a narrower question than device versus decompression.
  • Imaging severity is not a validated treatment-effect modifier; it may define anatomy without predicting benefit.
  • Reoperation must be reported with time, cause and competing repeat procedures.
  • A stable lumbar cohort cannot be transported to progressive DCM, where irreversible cord loss changes the risk balance.
  • Mean change should be accompanied by confidence intervals and responder proportions wherever the source reports them.
  • Frailty, falls, cognition, bone health and recovery destination are part of net benefit in an older population.

Open questions

  • Which symptom–exam–imaging combination best predicts decompression benefit? (Cook 2020, PMID 31312914; Katz 2022, PMID 35503342)
  • What constitutes clinically important lumbar instability requiring fusion? (Försth 2016, PMID 27074066; Austevoll 2021, PMID 34347953)
  • Can objective gait monitoring improve selection and follow-up? (Morimoto 2023, PMID 38162877)
  • Which mild cervical-myelopathy patients can be observed safely? (Fehlings 2017, PMID 29164035)
  • What explains long-term convergence between surgical and nonoperative SPORT cohorts? (Lurie 2015, PMID 25569524)

References

  1. Genevay S, et al. Lumbar spinal stenosis. Best practice & research. Clinical rheumatology. 2010;24:253-65. PMID 20227646
  2. Katz JN, et al. Diagnosis and Management of Lumbar Spinal Stenosis: A Review. JAMA. 2022;327:1688-1699. PMID 35503342
  3. Kuris EO, et al. Evaluation and Management of Cauda Equina Syndrome. The American journal of medicine. 2021;134:1483-1489. PMID 34473966
  4. Jensen RK, et al. Prevalence of lumbar spinal stenosis in general and clinical populations: a systematic review and meta-analysis. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2020;29:2143-2163. PMID 32095908
  5. Cook CJ, et al. Systematic review of diagnostic accuracy of patient history, clinical findings, and physical tests in the diagnosis of lumbar spinal stenosis. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2020;29:93-112. PMID 31312914
  6. Bussières A, et al. Non-Surgical Interventions for Lumbar Spinal Stenosis Leading To Neurogenic Claudication: A Clinical Practice Guideline. The journal of pain. 2021;22:1015-1039. PMID 33857615
  7. Ammendolia C, et al. Non-operative treatment for lumbar spinal stenosis with neurogenic claudication: an updated systematic review. BMJ open. 2022;12:e057724. PMID 35046008
  8. Comer C, et al. Exercise treatments for lumbar spinal stenosis: A systematic review and intervention component analysis of randomised controlled trials. Clinical rehabilitation. 2024;38:361-374. PMID 37715644
  9. Schneider MJ, et al. Comparative Clinical Effectiveness of Nonsurgical Treatment Methods in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial. JAMA network open. 2019;2:e186828. PMID 30646197
  10. Friedly JL, et al. A randomized trial of epidural glucocorticoid injections for spinal stenosis. The New England journal of medicine. 2014;371:11-21. PMID 24988555
  11. Weinstein JN, et al. Surgical versus nonoperative treatment for lumbar spinal stenosis four-year results of the Spine Patient Outcomes Research Trial. Spine. 2010;35:1329-38. PMID 20453723
  12. Lurie JD, et al. Long-term outcomes of lumbar spinal stenosis: eight-year results of the Spine Patient Outcomes Research Trial (SPORT). Spine. 2015;40:63-76. PMID 25569524
  13. Zaina F, et al. Surgical versus non-surgical treatment for lumbar spinal stenosis. The Cochrane database of systematic reviews. 2016;2016:CD010264. PMID 26824399
  14. Försth P, et al. A Randomized, Controlled Trial of Fusion Surgery for Lumbar Spinal Stenosis. The New England journal of medicine. 2016;374:1413-23. PMID 27074066
  15. Austevoll IM, et al. Decompression with or without Fusion in Degenerative Lumbar Spondylolisthesis. The New England journal of medicine. 2021;385:526-538. PMID 34347953
  16. Kgomotso EL, et al. Decompression alone or with fusion for degenerative lumbar spondylolisthesis (Nordsten-DS): five year follow-up of a randomised, multicentre, non-inferiority trial. BMJ (Clinical research ed.). 2024;386:e079771. PMID 39111800
  17. Gadjradj PS, et al. Decompression alone versus decompression with fusion in patients with lumbar spinal stenosis with degenerative spondylolisthesis: a systematic review and meta-analysis. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2023;32:1054-1067. PMID 36609887
  18. Schenck CD, et al. Interspinous process device versus conventional decompression for lumbar spinal stenosis: 5-year results of a randomized controlled trial. Journal of neurosurgery. Spine. 2022;36:909-917. PMID 34952518
  19. Fehlings MG, et al. A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression. Global spine journal. 2017;7:70S-83S. PMID 29164035
  20. McCormick JR, et al. Cervical Spondylotic Myelopathy: A Guide to Diagnosis and Management. Journal of the American Board of Family Medicine : JABFM. 2020;33:303-313. PMID 32179614
  21. Matz PG, et al. The natural history of cervical spondylotic myelopathy. Journal of neurosurgery. Spine. 2009;11:104-11. PMID 19769489
  22. Fehlings MG, et al. Riluzole for Degenerative Cervical Myelopathy: A Secondary Analysis of the CSM-PROTECT Trial. JAMA network open. 2024;7:e2415643. PMID 38904964
  23. Morimoto T, et al. Gait analysis using digital biomarkers including smart shoes in lumbar spinal canal stenosis: a scoping review. Frontiers in medicine. 2023;10:1302136. PMID 38162877
  24. Kreiner DS, et al. An evidence-based clinical guideline for the diagnosis and treatment of degenerative lumbar spinal stenosis (update). The spine journal : official journal of the North American Spine Society. 2013;13:734-43. PMID 23830297
  25. Ramesh A, et al. Aperius interspinous device for degenerative lumbar spinal stenosis: a review. Neurosurgical review. 2016;39:197-205; discussion 205. PMID 26324829